| Product Code: ETC7746507 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 Japan Predictive and Presymptomatic Testing Market Overview | 
| 3.1 Japan Country Macro Economic Indicators | 
| 3.2 Japan Predictive and Presymptomatic Testing Market Revenues & Volume, 2021 & 2031F | 
| 3.3 Japan Predictive and Presymptomatic Testing Market - Industry Life Cycle | 
| 3.4 Japan Predictive and Presymptomatic Testing Market - Porter's Five Forces | 
| 3.5 Japan Predictive and Presymptomatic Testing Market Revenues & Volume Share, By Condition, 2021 & 2031F | 
| 4 Japan Predictive and Presymptomatic Testing Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 Increasing awareness about preventive healthcare and personalized medicine | 
| 4.2.2 Growing demand for early disease detection and intervention | 
| 4.2.3 Technological advancements in genetic testing and analysis | 
| 4.3 Market Restraints | 
| 4.3.1 High costs associated with predictive and presymptomatic testing | 
| 4.3.2 Limited insurance coverage for such tests | 
| 4.3.3 Ethical and privacy concerns regarding genetic testing | 
| 5 Japan Predictive and Presymptomatic Testing Market Trends | 
| 6 Japan Predictive and Presymptomatic Testing Market, By Types | 
| 6.1 Japan Predictive and Presymptomatic Testing Market, By Condition | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 Japan Predictive and Presymptomatic Testing Market Revenues & Volume, By Condition, 2021- 2031F | 
| 6.1.3 Japan Predictive and Presymptomatic Testing Market Revenues & Volume, By Breast and Ovarian Cancer, 2021- 2031F | 
| 6.1.4 Japan Predictive and Presymptomatic Testing Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F | 
| 6.1.5 Japan Predictive and Presymptomatic Testing Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F | 
| 6.1.6 Japan Predictive and Presymptomatic Testing Market Revenues & Volume, By Multiple Endocrine Neoplasia Type - 2, 2021- 2031F | 
| 6.1.7 Japan Predictive and Presymptomatic Testing Market Revenues & Volume, By Haemochromatosis, 2021- 2031F | 
| 7 Japan Predictive and Presymptomatic Testing Market Import-Export Trade Statistics | 
| 7.1 Japan Predictive and Presymptomatic Testing Market Export to Major Countries | 
| 7.2 Japan Predictive and Presymptomatic Testing Market Imports from Major Countries | 
| 8 Japan Predictive and Presymptomatic Testing Market Key Performance Indicators | 
| 8.1 Percentage increase in the number of individuals opting for predictive and presymptomatic testing | 
| 8.2 Adoption rate of new genetic testing technologies in the market | 
| 8.3 Average turnaround time for test results and counseling services provided | 
| 8.4 Number of partnerships and collaborations between testing companies and healthcare providers | 
| 8.5 Rate of reimbursement approvals for predictive and presymptomatic testing by insurance companies | 
| 9 Japan Predictive and Presymptomatic Testing Market - Opportunity Assessment | 
| 9.1 Japan Predictive and Presymptomatic Testing Market Opportunity Assessment, By Condition, 2021 & 2031F | 
| 10 Japan Predictive and Presymptomatic Testing Market - Competitive Landscape | 
| 10.1 Japan Predictive and Presymptomatic Testing Market Revenue Share, By Companies, 2024 | 
| 10.2 Japan Predictive and Presymptomatic Testing Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |